@NEJMGroup

Information about NEJM Group products and services. Follow @NEJM, @NEJMCatalyst, @NEJMEvidence, @NEJM_AI, @NEJMres360, @NEJMkplus, and @JWatch.

 Boston
nejmgroup.org/
Joined December 2011
  • Tweets2.7K
  • Following174
  • Followers9.3K
765Media
This Twitter account is no longer active. For up-to-date information and articles from NEJM Group, follow @NEJM, @NEJMCatalyst, @JWatch, @Physns1stWatch, @NEJMres360, @nejmkplus, and @NEJMLibHub.
1
1
2
An FDA advisory committee voted on Thursday that the potential benefits of the Pfizer and BioNTech #COVID19 #vaccine outweigh its risks for people ages 16 years and up.

2
25
3
61
Celebrating our anniversary today! 🎉 One year ago, we launched NEJM Catalyst Innovations in Care Delivery. NEJM Catalyst itself turns five. Please enjoy some virtual cake, on us. 🍰

1
4
1
20
#ASH2020: A preliminary study shows that patients on chronic anticoagulant or antiplatelet drugs for other conditions do not fare better than other patients after receiving a diagnosis of #COVID19. Dr. Gwendolyn Ho chats with @NEJMGroup’s Joe Elia. jwat.ch/39R6Jb2
11
2
28
.@PaulSaxMD offers some tips for getting through the next few months safely -- and with some joy -- while we await widespread vaccination against #COVID19. jwat.ch/2VHpAgu

Getting Through a Grim, Dark Winter with Little Bits of Joy

The season’s first nor’easter came barreling through New England this weekend, bringing with it an added level of gloom to an already pretty grim time. Grim because the virus sadly returned right on...

blogs.nejm.org
7
13
Pfizer and BioNTech's mRNA #vaccine against #SARSCoV2 seems to start working soon after the first dose. Meanwhile, the AstraZeneca vaccine showed 62% efficacy among people who received two full doses and 90% efficacy among those who received a half-dose followed by a full dose.

5
34
2
71
A preliminary study in California shows that patients on chronic anticoagulant or antiplatelet drugs for other conditions don't fare any better than other patients after receiving a diagnosis of #COVID19. Dr. Gwendolyn Ho chats with Joe Elia. jwat.ch/39R6Jb2 #ASH20
10
1
19
#ASH20 news from @NEJMGroup: Joe Elia interviews Dr. Bhavana Bhatnagar. She reports that African-American patients aged <60 with acute myeloid leukemia have lower 3-year survival compared with whites: 32% vs. 41%. jwat.ch/39P1BUL @BhavanaBhatnag4
3
3
3
7
#ASH2020 news from @NEJMGroup: Dr. Terry Gernsheimer discusses her team's research on the prophylactic use of tranexamic acid in patients undergoing treatment for hematologic malignancies jwat.ch/2LdbCRB
3
14
Inhaled corticosteroids can be used as needed to manage symptoms in patients aged 12 years and up with mild or moderate persistent #asthma, according to updated asthma guidelines from the National Asthma Education and Prevention Program.

2
18
5
68
Pooled #SARSCoV2 Surveillance Testing at a U.S. University: Benefits and Costs jwat.ch/3lvdDF1 #COVID19
1
2
9
The CDC has shortened the minimum amount of time people have to quarantine after a potential #COVID19 exposure from 14 days to as few as 7 days as long as the person is symptom free and tests negative.

21
6
51
Anticholinergic medications increase the risk for #MildCognitiveImpairment in cognitively normal adults: jwat.ch/37uhzBf
1
20
3
61
What is your organization doing to advance the transformation of health care? Visit our author center and let us know: catalyst.nejm.org/author-cen… #HealthCareDelivery #HCLDR #HealthCareInnovation

3
4
1
10
The CDC's advisory committee voted 13-1 on Tuesday in favor of prioritizing both healthcare workers and residents of long-term-care facilities for vaccination against #SARSCoV2 during the initial phase of vaccination. #vaccine #COVID19

2
25
1
51
From the Insights on Residency Training blog: @VivekSantMD, who has seen residents collectively judge each new class of interns since his own intern year, muses about the culture shift he sees happening in residency training today. jwat.ch/3fySo46
2
6
4
25
.@PaulSaxMD summarizes great ID questions from a recent online course he co-teaches at Harvard Medical School. jwat.ch/33uMaNP

Great Questions from Our Course, Infectious Diseases in Primary Care -- Plus Bonus Podcast

Going to take a partial break from all things COVID-19 today and recap some of the terrific questions we received in our course, Infectious Diseases in Primary Care. Not surprisingly, there were...

blogs.nejm.org
1
8
1
21
In response to its outstanding reception, NEJM Catalyst Innovations in Care Delivery is doubling its frequency to 12 issues per year. Learn about the journal and visit our author center: catalyst.nejm.org/about/jour… #HealthCareDelivery #HCLDR #HealthCareInnovation

7
13
.@PaulSaxMD offers his list of ID-related things to be thankful for (even in 2020) in his HIV and ID Observations blog. jwat.ch/3ftb8BX

Some ID Things to Be Grateful for This Holiday Season -- 2020 (!) Edition

“Grateful?” some might wonder. “He must be out of his mind.” But even in the cursed year that began shortly after the first report of the disease now known as COVID-19 on (almost) New Year’s Eve, we...

blogs.nejm.org
6
1
16
The FDA has issued emergency use authorizations for two new #COVID19 treatments, including the antibody cocktail President Donald Trump received early in his illness.

2
20
4
37
Load more